Notwithstanding, their group previously reported that loss of PTEN upregulated VEGF and CCL2 and resulted in lower responses to immunotherapy in a mouse model of melanoma and that VEGF and PTEN protein expression inversely correlated in clinical samples22. The gene discussed is VEGFA; the disease is melanoma.